EDBI Pte Ltd’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $160K | Hold |
10,105
| – | – | 0.17% | 14 |
|
|
2024
Q3 | $587K | Hold |
10,105
| – | – | 0.79% | 13 |
|
|
2024
Q2 | $462K | Hold |
10,105
| – | – | 0.52% | 15 |
|
|
2024
Q1 | $669K | Hold |
10,105
| – | – | 0.75% | 13 |
|
|
2023
Q4 | $402K | Hold |
10,105
| – | – | 0.4% | 17 |
|
|
2023
Q3 | $322K | Hold |
10,105
| – | – | 0.35% | 16 |
|
|
2023
Q2 | $406K | Hold |
10,105
| – | – | 0.33% | 16 |
|
|
2023
Q1 | $431K | Hold |
10,105
| – | – | 0.48% | 16 |
|
|
2022
Q4 | $485K | Hold |
10,105
| – | – | 0.62% | 15 |
|
|
2022
Q3 | $380K | Hold |
10,105
| – | – | 0.4% | 19 |
|
|
2022
Q2 | $279K | Hold |
10,105
| – | – | 0.26% | 18 |
|
|
2022
Q1 | $550K | Hold |
10,105
| – | – | 0.37% | 17 |
|
|
2021
Q4 | $591K | Buy |
+10,105
| New | +$591K | 0.32% | 13 |
|